← Back to Search

CTR with PRP for Carpal Tunnel Syndrome

N/A

Waitlist Available

Research Sponsored by Michael Fredericson, MD

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months post-op

Awards & highlights

Study Summary

This trial is studying if adding platelet-rich plasma to carpal tunnel release surgery can help improve outcomes for patients with severe carpal tunnel syndrome.

Eligible Conditions

Carpal Tunnel Syndrome
Platelet Rich Plasma

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months post-op

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months post-op

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months post-op for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Boston Carpal Tunnel Questionnaire

Grip Strength

Secondary outcome measures

2 Point Discrimination at Index Finger

2 Point Discrimination at Middle Finger

2 Point Discrimination at Thumb

+8 more

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: CTR with PRPActive Control1 Intervention

Carpal tunnel release with adjuvant platelet-rich plasma.

Group II: CTR without PRPPlacebo Group1 Intervention

Carpal tunnel release without adjuvant platelet-rich plasma.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Michael Fredericson, MDLead Sponsor

Factor MedicalUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the cap on the number of individuals participating in this medical study?

"Affirmative. Per the information posted on clinicaltrials.gov, this medical trial is currently seeking participants; it was initially published in October 2021 and updated most recently in April 2022. 46 volunteers are needed to be enrolled at a single site for this study."

Answered by AI

Are there still opportunities for enrollment in this research endeavor?

"Confirmation on clinicaltrials.gov confirms that this medical study, first posted on October 15th 2021 is actively recruiting patients. This information was last revised on April 18th 2022."

Answered by AI

What benefits does this research strive to achieve?

"The primary end-point of this 12 month clinical trial is a patient's Grip Strength. The secondary outcomes encompass two point discrimination (at thumb and middle finger), as well as Median Motor Latency, all evaluated via EMG/NCS testing."

Answered by AI

Recent research and studies

Scientific ReportsJournal

Efficacy of Platelet-rich Plasma as an Adjuvant to Surgical Carpal Ligament Release: A Prospective, Randomized Controlled Clinical Trial

Trull-Ahuir, Carmen, Diego Sala, Joaquín Chismol-Abad, Marian Vila-Caballer, and Juan Francisco Lisón. 2020. “Efficacy of Platelet-rich Plasma as an Adjuvant to Surgical Carpal Ligament Release: A Prospective, Randomized Controlled Clinical Trial”. Scientific Reports. Springer Science and Business Media LLC. doi:10.1038/s41598-020-59113-0.

clinicaltrials.govStudy

PRP as Adjuvant Treatment to CTR for Severe CTS Tunnel Syndrome

Michael Fredericson, MD 2021. "PRP as Adjuvant Treatment to CTR for Severe CTS Tunnel Syndrome". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04811287.